|
|
Volumn 1, Issue 2, 2005, Pages 88-95
|
|
Drug Insight: temozolomide as a treatment for malignant glioma--impact of a recent trial.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKYLATING AGENT;
DACARBAZINE;
DNA METHYLTRANSFERASE;
DRUG DERIVATIVE;
TEMOZOLOMIDE;
BRAIN TUMOR;
CLINICAL TRIAL;
DRUG RESISTANCE;
GENETICS;
GLIOBLASTOMA;
HUMAN;
PATHOPHYSIOLOGY;
PROGNOSIS;
REVIEW;
STATISTICS;
ANTINEOPLASTIC AGENTS, ALKYLATING;
BRAIN NEOPLASMS;
CLINICAL TRIALS;
DACARBAZINE;
DNA MODIFICATION METHYLASES;
DRUG RESISTANCE, NEOPLASM;
GLIOBLASTOMA;
HUMANS;
PROGNOSIS;
|
|
EID: 33749259947
PISSN: 1745834X
EISSN: None
Source Type: Journal
DOI: 10.1038/ncpneuro0045 Document Type: Review |
|
Times cited : (53)
|
|
References (44)
|
